Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs Midazolam+Fentanyl for GI Endoscopy Sedation
NCT04807101Phase 1Completed
- Sponsor
- Greg S Cohen MD
- Start
- Apr 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of midazolam in conscious sedation (2 arms), sponsored by Greg S Cohen MD. Primary endpoints: Pain Felt During the Procedure at 1 day and Adequacy of Sedation at 1 day. Started Apr 2021; status: completed.
02
Drugs
midazolam
03
Conditions
conscious sedation
Beyond the preview
Go deeper on NCT04807101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04807101.